FERSISI BACTERIOPHAGE UNGUENTUM

Composition
Fersisi bacteriophage is a sterile filtrate of phage lysates to

• Staphylococcus (S. aureus, S. epidermis) titter no less than 10ml.
• Streptococcus (S. pyogenes, S. sanguis, S. salivarius, S. agalactiae ) titter no less than 10ml.

Inactive ingredients Bacteriological growth medium, standard sodium saline. Chinazolin as a conservator.

Pharmacological specifications
Pharmaco-therapeutical group
Specific antibacterial solution

Pharmacological actions
Fersisi Bacteriophage leads to specific lysis of bacteria belonging to Staphylococci and Streptococci.

Prescription
To be used with curative and prophylaxis aim in pyo-inflammatory and enteric infections caused by the above-mentioned microorganisms.

Indications
Otolaryngological diseases: inflammation of the middle ear, tonsillitis, laryngitis, rhinitis, tracheitis, bronchitis, pneumonia, pleurisy.

Skin infections: furunculosis, carbunculosis, abscess, deep infiltration and abscessing sycosis.

Surgical diseases: Abscess, wound infections, mastitis, osteomyelitis, phlegmon.

Inflammation of oral cavity: stomatitis, gingivitis, etc.

Eye diseases: bacterial conjunctivitis: Secondary infections with thermal burns.

Urogenital and gynecologic infections: urethritis, cystitis, pyelonephritis, endometritis.

Enteric infections: gastroenterocolitis, cholecystitis, staphylococcal toxic infection, dysbacteriosis.

Pyo - inflammatory disease in children (including newborns) prevention of postoperative periods and hospital infection.

Treatment should continue for 6-10 days.

Contra-Indications
There are no contraindications ever observed for FERSISI bacteriophage, The use of FERSISI bacteriophage does not exclude concomitant use of antibiotics or any other medicine.

Packaging and Storage Conditions

The preparation comes in a 20g jar.

Hide from the daylight.

Shelf life: 6 months.

Conditions of release: Out of prescription)

Developed by: G.Eliava Institute of bacteriophage, Microbiology and virology.